Posted by Michael Wonder on 21 Feb 2023
NICE recommends 3 treatments for COVID-19 in final draft guidance
21 February 2023 - Everyone with COVID-19 at highest risk of developing severe disease will have access to clinically and cost-effective treatments, under final draft guidance published by NICE today.
People at highest risk of developing severe disease include those who are immunosuppressed (for example, as a result of chemotherapy or having had an organ transplant), or who have other conditions such as heart disease, respiratory disease, diabetes, or neurological conditions.
